Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NOICH Study
NL-OMON21014Active, not recruiting
- Sponsor
- Sanquin
- Start
- Jan 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised trial of immune globulin in fetomaternal alloimmune thrombocytopenia (FMAIT) (2 arms), sponsored by Sanquin. Primary endpoint: Number of neonates with intracranial hemorrhage. Started Jan 2005; status: active, not recruiting.
02
Drugs
immune globulin
03
Conditions
fetomaternal alloimmune thrombocytopenia (FMAIT)
Beyond the preview
Go deeper on NL-OMON21014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21014.